![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 37, 33670-33675, September 13, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of
Received for publication, April 29, 2002, and in revised form, June 26, 2002
The nicotinamide nucleotide
transhydrogenases of mitochondria and bacteria are proton pumps that
couple direct hydride ion transfer between NAD(H) and NADP(H) bound,
respectively, to extramembranous domains I and III to proton
translocation by the membrane-intercalated domain II. To delineate the
proton channel of the enzyme, 25 conserved and semiconserved
prototropic amino acid residues of domain II of the Escherichia
coli transhydrogenase were mutated, and the mutant enzymes were
assayed for transhydrogenation from NADPH to an NAD analogue and for
the coupled outward proton translocation. The results confirmed the
previous findings of others and ourselves on the essential roles of
three amino acid residues and identified another essential residue.
Three of these amino acids, His-91, Ser-139, and Asn-222, occur in
three separate membrane-spanning Nicotinamide nucleotide transhydrogenases
(TH)1 of mitochondria and
microorganisms are membrane-intercalated enzymes that catalyze the
direct and stereospecific transfer of a hydride ion between the 4A
position of NAD(H) and the 4B position of NADP(H). This transhydrogenation reaction is coupled to transmembrane proton translocation with a H+/H This paper concerns the proton channel of TH in the
membrane-intercalated domain II of E. coli. Extensive
site-directed mutagenesis studies have culminated in the identification
of four amino acid residues, one each in domain II Materials--
NAD, NADH, NADPH, and ATP were obtained from
Calbiochem. AcPyAD, AcPyADP, and 9-amino-6-chloro-2-methoxyacridine
(ACMA) were obtained from Sigma. E. coli strain
MC4100TH Site-directed Mutagenesis--
The wild type transhydrogenase
gene (pDC21) was digested with SalI/BamHI, and
the resulting DNA fragment was inserted into the
SalI/BamHI site of pTZ18U. With this plasmid
derivative, site-directed mutagenesis was carried out using the
reagents and protocols outlined in the Bio-Rad Muta-Gene mutagenesis
kit (19). The plasmid DNA was prepared from individual colonies, and
mutants were identified by DNA sequencing. The mutant DNA fragment was
excised by appropriate restriction enzymes and replaced with the
counterpart of pDC21.
Culture of E. coli Cells--
The E. coli strain
MC4100TH Preparation of Membranes--
The cells (wet weight, ~ 0.65 g/liter LB medium) were suspended in 20 ml of 50 mM
Tris-HCl (pH 7.8), containing 1 mM dithiothreitol and 5 mM MgC12 and sonicated in a Branson Sonifier at
output 8 and 25% pulse for 5 min. Unbroken cells were removed by
centrifugation at 15,000 rpm for 10 min in a Beckman model L
ultracentrifuge, and membranes were collected by centrifugation at
40,000 rpm for 45 min. Membranes were suspended in 1.3 ml of the same
buffer and homogenized.
Enzyme Assays--
Reverse transhydrogenase activity was assayed
spectrophotometrically at 375 nm in a 37 °C reaction mixture (1 ml)
containing 50 mM sodium phosphate (pH 7.0), 0.2 mM NADPH, 0.2 mM AcPyAD, and E. coli
membranes (5-50 µg of protein). Cyclic transhydrogenase activity was
measured at 375 nm in a 37 °C reaction mixture (1 ml) containing 50 mM MES-KOH (pH 6.0), 0.2 mM NADH, 0.2 mM AcPyAD, 10 µM NADPH, and E. coli membranes (5-50 µg of protein). ATP-dependent forward transhydrogenase activity was measured in a reaction mixture (1 ml) containing 50 mM Tris-H2SO4 (pH
7.8), 5 mM MgCl2, 2 mM dithiothreitol, 0.3 M KC1, 0.2 mM NADH, and 0.2 mM AcPyADP. This reaction was started by the addition of
E. coli membranes (20-50 µg of protein), and 2-3 min
later, 5 µl of 0.2 M ATP were added. The reduction of
AcPyADP before and after ATP addition was monitored at 375 nm. An
extinction coefficient of 6.1 mM Proton Translocation--
Proton translocation coupled to
reverse transhydrogenation catalyzed by E. coli
membranes was monitored by measuring the quenching of ACMA
fluorescence. The reaction mixture (2 ml) contained 10 mM
HEPES-KOH (pH 7.4), 5 mM MgCl2, 0.3 M KCl, 2 µM ACMA, 0.2 mM NADPH,
0.4 mM AcPyAD, and E. coli membranes (10-100
µg of protein). ACMA fluorescence was measured at 37 °C by a
SLM photon-counting fluorescence spectrophotometer using an
excitation wavelength of 415 nm and an emission wavelength of 485 nm.
The reaction was started by the addition of AcPyAD. Proton
translocation coupled to ATP hydrolysis or NADH oxidation was measured
similarly in the above reaction mixture with the exception that NADPH
and AcPyAD were not included and the reaction was started by the
addition of 200 µM ATP or 50 µM NADH.
Protein Determination.--
Protein concentration was determined
using the BCA protein assay reagents (Pierce).
Meuller and Rydström (20) have shown that the
membrane-intercalated domain II of the two-subunit E. coli
TH monomer is composed of 13 transmembrane
The Proton Channel of the Energy-transducing Nicotinamide
Nucleotide Transhydrogenase of Escherichia coli*
,
¶
Molecular and Experimental
Medicine and § Molecular Biology, The Scripps Research
Institute, La Jolla, California 92037
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
helices of domain II of the
subunit of the enzyme. Another residue, Asp-213, is probably located in
a cytosolic-side loop that connects to the
helix bearing Asn-222.
It is proposed that the three helices bearing His-91, Ser-139, and
Asn-222 come together, possibly with another highly conserved
helix
to form a four-helix bundle proton channel and that Asp-213 serves to
conduct protons between the channel and domain III where NADPH binding
energy is used via protein conformation change to initiate outward
proton translocation.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
stoichiometry of
unity as shown in Equation 1 (1-3).
The amino acid sequences of >30 TH are available, but only the
enzymes from bovine mitochondria (4), Escherichia coli (5),
and Rhodobacter capsulatus (6) have been purified. The
bovine enzyme is a homodimer of monomer molecular mass of 109,065 Da.
The monomer is composed of three domains: an amino-terminal 430-residue-long extramembranous domain I that binds NAD(H), a 400-residue-long central domain II that is composed of 14 transmembrane
(Eq. 1)
helices, and a carboxyl-terminal 200-residue-long extramembranous domain III that binds NADP(H) (1, 4, 7). The extramembranous domains I
and III come together in the mitochondrial matrix to form the catalytic
site of the enzyme. Bovine TH does not have a protein mass on the
cytosolic side of the mitochondrial inner membrane with the exception
of the oligopeptide loops, which connect appropriate transmembrane
helices (8). The prokaryotic enzymes have the same general tridomain
structure, but each monomer is made up of two (E. coli and
R. capsulatus TH) or three (Rhodospirillum rubrum TH) subunits (1, 4, 5). In 1995, we discovered an
interesting feature of the transhydrogenase (9). Because hydride ion
transfer between NAD(H) bound to domain I and NADP(H) bound to domain
III is direct, we reasoned that the respective nicotinamide moieties of
these nucleotides must come within a few angstroms of each other for
such direct hydride ion transfer to take place. If so, we further
reasoned that the nucleotide binding regions of domains I and III must
have complementary surfaces and attractive forces to allow the close
approximation of the nicotinamide rings of their respective
nucleotides. If these considerations were correct, then soluble domains
I and III in the absence of the membrane-intercalated domain II might
come together and catalyze transhydrogenation. This reasoning proved
correct. We demonstrated that indeed isolated or recombinant
transhydrogenase domains I and III from the same or different organisms
did catalyze transhydrogenation when added to a reaction mixture in the
absence of domain II (9) and that this transhydrogenation was
especially efficient with recombinant R. rubrum domains I
and III (10). The kinetics of transhydrogenation as catalyzed by
recombinant domains I and III were subsequently further explored by
others (11-13). The crystal structures of recombinant bovine (14) and
human (15) domain III containing bound NADP, recombinant R. rubrum domain I containing bound NAD (16), and a recombinant
R. rubrum domain I-III complex containing a domain I dimer
with one mole of NAD bound to each monomer plus a domain III monomer
with bound NADP (17) have been published. In addition, we have recently
determined the crystal structure of recombinant R. rubrum
domain I dimer in the absence and the presence of bound
NADH.2
helices 9, 10, and 13 and one in the loop connecting
helices 12 and 13, which
appear to be required for coupled proton translocation by TH. On the
basis of these and previous results, a mechanism for proton
translocation coupled to transhydrogenation has been proposed.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, whose transhydrogenase gene was replaced with
the kanamycin resistance gene, was reported previously (18).
was transformed with pDC21 or mutant plasmids.
Each single colony was inoculated into the LB medium containing
ampicillin (100 µg/ml) and kanamycin (25 µg/ml). Cells were grown
aerobically at 37 °C until the late logarithmic phase, collected by
centrifugation at 8,000 rpm for 5 min (Sorvall GSA rotor), and washed
with 0.9% NaC1.
1 cm
1 was used to calculate
the rates.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
helices, 4 helices at
the COOH terminus of the
subunit and 9 helices at the
NH2 terminus of the
subunit. The domain II of the
single subunit bovine TH monomer is composed of 14 continuous
transmembrane
helices (1, 4). Meuller and Rydström (20)
showed that the E. coli TH lacks the segment corresponding
to the fifth bovine
helix and recommended that for easy
interspecies comparison, the transmembrane
helices of E. coli TH be designated as shown in Fig.
1 (i.e. the
subunit ending
with helix 4 and the
subunit starting with helix 6).

View larger version (29K):
[in a new window]
Fig. 1.
Domain II of E. coli
TH. The essential residues
His-91,
Ser-139,
Asp-213, and
Asn-222 are highlighted in black circles.
Glu-85 is in a black square, and the conserved glycine
residues of helices 9, 10, 13, and 14 are shown in bold. For
details, see "Results." This figure was adapted from that in Ref.
20.
For reasons that are detailed under "Discussion" (also for review
see Ref. 1), we considered that the proton channel of TH is probably
located in the segment of the
subunit between transmembrane
helices 9 and 14. Therefore, a systematic mutational study was
undertaken in which the effects of mutations of prototropic residues
were investigated, mainly in this segment of domain II of the E. coli TH. The mutant E. coli membranes were assayed for the following activities: reverse transhydrogenation from NADPH to the
NAD analogue AcPyAD; cyclic transhydrogenation in the presence of NADPH
from NADH to AcPyAD (10, 21, 22); proton translocation coupled to
reverse transhydrogenation; and proton translocation coupled to ATP
hydrolysis and/or NADH oxidation. The latter assays were considered
important controls, because they checked membrane integrity where TH
mutations appeared to have inhibited transhydrogenation-coupled proton
translocation. The results obtained have been separated into two
tables. Table I shows the results of the
mutations of 21 conserved and semiconserved (with the exception of
Lys-149) prototropic residues, which appeared to be nonessential. As
seen in this table, certain mutations had large effects on one or more of the activities tested. In the absence of information regarding the
overall structure of the TH molecule, it is difficult to rationalize the effects of these mutations on the TH activities shown in Table I.
However, certain possibilities can be conceived regarding the results
of mutations of
Glu-85, which are considered under "Discussion."
|
Table II shows the results of mutations
of four other prototropic residues of the
subunit of TH domain II.
As was shown previously by others and confirmed here,
His-91 (23)
and
Asn-222 (24) appeared to be essential residues. One reason for
repeating and extending the mutational studies of others was that they
had not stated whether their E. coli membrane preparations
containing the TH mutants incapable of transhydrogenation coupled
proton translocation were otherwise intact and capable of forming a
proton electrochemical potential coupled to ATP hydrolysis and/or
respiration. Although not shown in Tables I and II, we carried out this
important membrane integrity test in all of the cases where proton
translocation rates and extents coupled to reverse transhydrogenation
were nil or drastically diminished. The results showed that all the
E. coli membrane preparations containing TH mutants with
impaired proton translocation activity were capable of rapid proton
translocation coupled to ATP hydrolysis and NADH oxidation. Another
reason was that certain literature reports showed substantial
proton translocation activity for mutants that exhibited negligible
reverse TH activity (see below).
|
As seen in Table II, the mutation of
His-91 appeared to be tolerated
to various low extents for reverse and cyclic transhydrogenation but
not for proton translocation. Among the
His-91 mutations, the
replacement of this residue with Asn did not alter the reverse TH
activity but greatly diminished cyclic and proton translocation activities. Literature data on the activities of
H91N mutation are
mixed. The reverse TH activity reported for this mutation ranges from
80 (25-27) to 18% (28) relative to the wild type activity. However,
these reports agree that
H91N mutation greatly inhibits proton
translocation. It has been reported that
H91K and
H91R mutants
exhibit relative to the wild type, respectively, 2 and 1% reverse TH
activity, and 30 and 25% proton pumping activity (28). As seen in
Table II, our
H91K and
H91R mutants were not only impaired for
reverse transhydrogenation, they were also incapable of proton
translocation. In the TH of certain microorganisms (e.g.
Mycobacteria), the residue corresponding to
His-91 is
Asn. In these organisms, the amino acid residues following Asn are also
different. In E. coli, the sequence starting at
His-91 is HSFVGLA, whereas in Mycobacterium leprae and
Mycobacterium tuberculosis, the sequence is NGVGGGT.
Whether the TH in these organisms is incapable of proton translocation
or more probably the nearby residue changes make it possible for Asn to
perform the same function as
His-91 of E. coli TH remains
to be seen (see also Ref. 29). However, it should be mentioned that in
these organisms the residues corresponding to the other three essential
residues shown in Table II are all conserved. As seen in Tables I and
II, cyclic TH activity is generally close to reverse TH activity with
the exception of the case of
H91K mutation (Table II) where reverse
TH activity is greatly diminished but cyclic activity is very high.
This may be related to the finding of Bragg and Hou (28) that
H91K
mutants contain bound NADP(H), which would favor the cyclic reaction
(1, 10, 21, 22).
Another domain II residue previously shown to affect TH catalytic and
proton translocation activities when mutated is
Asn-222 (24). Our
extensive mutational data in support of the essential role of
Asn-222 are shown in Table. II. It is seen that in contrast to all
of the other
Asn-222 mutations, which completely inhibited proton
translocation,
N222C and
N222D exhibited a low level of proton
translocation activity (see also Ref. 24). This observation is not
inconsistent with our proposed mechanism of proton translocation by TH
(see "Discussion").
We had shown earlier that
Asp-213, the only conserved dicarboxylic
acid residue in the entire domain II of TH, appears to play a role in
proton translocation (18). Its mutation to Asn and Ile resulted in
parallel losses, respectively, of 70 and 90% reverse
transhydrogenation and proton translocation activities. The results of
additional mutations of this residue shown in Table II support our
previous findings. It is seen that the mutation of
Asp-213 to Glu
was partially tolerated, but other mutations greatly inhibited
catalytic activity and nearly completely abolished proton
translocation activity. Our results regarding the mutation of
Asp-213 to Lys and Arg differ from those of others. Bragg and Hou
(28) have reported that as compared with wild type,
D213K exhibited
7% reverse and 49% proton translocation activities and
D213R
showed 5% reverse and 28% proton translocation activities. Bragg and
Hou (28) do not explain how it is possible for the rate of the
exergonic reverse transhydrogenation to be so much lower than the rate
of the coupled endergonic proton translocation (see also above for data
on
H91K and
H91R mutants). We appreciate that the different
monitoring methods used (absorbance versus fluorescence) can
result in small differences between the estimated rates of hydride ion
transfer and proton translocation, especially when the results are
calculated as percent of wild type activities. However, in our hands,
H91K and
H91R were incapable of proton translocation (see above
and Table II), and
D213K and
D213R exhibited marginal rates of
proton translocation commensurate with their very low reverse
transhydrogenation activities.
The finding that
Ser-139 appears to be essential is new and agrees
with our previous suggestion regarding the possible role of conserved
hydroxylated residues, which are prevalent in the distal helices of
domain II (1). The situation with
Ser-139 is particularly
interesting. As seen in Table II, this residue could not tolerate the
mutation to Ala, Asp, His, Lys, Leu, or Asn. In all of these cases,
proton translocation was completely abolished. However, the replacement
of the hydroxymethyl group of
Ser-139 with the hydroxyethyl of
threonine or the thiomethyl of cysteine was tolerated. These results as
well as the permissible
S139G mutation are understandable in terms
of our concept regarding the mechanism of proton translocation by TH,
which is described under "Discussion."
| |
DISCUSSION |
|---|
|
|
|---|
The Proton Channel of TH--
The reason for concentrating our
domain II mutagenesis studies on the segment of this domain downstream
of helix 8 was that this region contains a highly conserved sequence of
amino acids, especially around
His-91 in helix 9, around
Ser-139
in helix 10, in the extramembranous loop connecting helices 12 and 13, and throughout the remainder of domain II and approximately 15 residues
in the extramembranous region beyond helix 14. This high degree of
sequence conservation is rare among the hydrophobic domains of other
proteins and was therefore suggestive of functional significance. The
data reported in Tables I and II show that among 25 conserved and
semiconserved prototropic residues of domain II of the E. coli TH, which were mostly located in helices 9-14, four
residues, namely,
His-91,
Ser-139,
Asp-213, and
Asn-222, appear to be essential for proton translocation.
Asp-213 is
considered to be located outside the membrane in a cytosolic-side loop
that connects transmembrane helices 12 and 13, whereas
His-91,
Ser-139, and
Asn-222 are located, respectively, in helices 9, 10, and 13 (Fig. 1). We propose that in the native structure of TH,
helices 9, 10, and 13 come together possibly with the highly conserved helix 14 to form a four-helix bundle in which residues
His-91,
Ser-139, and
Asn-222 participate together with bound water
molecules in a hydrogen-bonded network for proton conductance (see also Ref. 29). The participation of bound water in proton conductance has
been demonstrated in bacteriorhodopsin (30-32) and appears very likely
in cytochrome c oxidase (33-35). In Fig. 1,
His-91,
Ser-139, and
Asn-222 are shown at approximately the same depth from either side of
helices 9, 10, and 13. However, it should be
pointed out that the correct structure of domain II is not known, and
it is possible that these essential residues are located in such
positions in their respective
helices that together with bound
water they span the membrane from the cytosolic to the periplasmic
side. Furthermore, it may be noted that dispersed throughout the
proposed four-helix bundle are eight conserved glycines in the 33 available TH sequences. In the E. coli TH (see Fig. 1) these
conserved glycines are
Gly-95 in helix 9,
Gly-132 (Ala in
Eimeria tenella) and
Gly-138 in helix 10,
Gly-226 and
Gly-233 in helix 13, and
Gly-245,
Gly-249 (Ala in E. tenella), and
Gly-252 in helix 14. Together these conserved
glycines may be required for the formation of a channel for bound water
within the proposed four-helix bundle.
A proton channel as proposed here would agree with the mutational data
reported in Table II. Thus, the permissible mutations
S139T and
S139C are understandable, because the hydroxyethyl group of
threonine and the thiomethyl group of cysteine could easily be
considered to perform the same role as the hydroxymethyl of serine in
the hydrogen bond network described above. The low proton translocation
activities of
N222D and
N222C could also be rationalized in terms
of the ability of Asp and Cys to participate via hydrogen bonding in
proton conductance. Furthermore, the permissible
S139G mutation is
not as surprising as it seems. One can conceive of the vacancy created
by the absence of the hydroxymethyl of serine to be filled with a
molecule of water and its participation in proton conductance through
the hydrogen bond network. As seen in Table I, the mutations of
Glu-85 resulted in variable low activities. It is difficult to
consider
Glu-85 as an essential residue, because in the TH of many
organisms,
Glu-85 is replaced with Gln and because all of the
Glu-85 mutations shown in Table I were tolerated to variable small
extents. However, the location of
Glu-85 is of interest
(a) because of its proximity to
His-91 in the
helical
structure of helix 9, and (b) because in the proposed helix
bundle,
Glu-85 may come close to
Asp-213 and assist in efficient
proton conductance from
Asp-213 into the proton channel (see below).
We have checked the possibility that in the E. coli TH
Glu-85 may take part together with
Asp-213 in proton conductance
between domains II and III by mutating both residues to Ala. The
resulting
E85A/
D213A double mutant showed only 1% reverse TH
activity as compared with wild type and was completely incapable of
proton translocation.
The TH Energy Coupling Mechanism--
As seen in
Equation 1, reverse transhydrogenation from NADPH to NAD is coupled to
outward proton translocation. Because the difference in the reduction
potentials of NADPH/NADP and NADH/NAD couples is negligible
(
E
Our early studies provided support for the above expectations. We first
obtained evidence in submitochondrial particles that TH utilizes the
proton motive force for cyclic conformation change in forward
transhydrogenation (1, 36) and demonstrated a proton motive
force-promoted substrate affinity increase of ~9-10 kJ/mol during
hydride ion transfer from NADH to the NADP analogue AcPyADP (1, 4, 37,
38). Finally, using purified bovine TH, we showed for the first time
that the binding of NADPH but not of NADH, NAD, or NADP, made two
distant peptide bonds (Lys410-Thr411 at the
junction of domains I and II and
Arg602-Leu603 in the domain II
extramembranous loop connecting
helices 6 and 7) susceptible to
trypsin hydrolysis (4, 39). These results indicated that NADPH binding
at domain III alters the conformation of this domain and its position
relative to domains I and II. This finding was subsequently supported
by data for the E. coli enzyme (40).
We have now shown that the conserved
Asp-213 of E. coli
TH, which is probably located in the domain II extramembranous loop connecting
helices 12 and 13, is necessary for efficient proton translocation coupled to reverse transhydrogenation (Table II). This
finding provides for a mechanism whereby the NADPH-promoted conformation change of domain III can be linked to the proton channel
of the enzyme in domain II (see above). It has been suggested by others
that the conserved
Asp-392 at the NADPH binding site may be involved
in proton translocation (41). One can certainly conceive of the
possibility that the NADPH-promoted conformation change of domain III
makes it possible for
Asp-392 to release a proton, which would
somehow be conveyed to the domain II proton channel via
Asp-213
(Fig. 2). As mentioned above, the
NADPH-promoted conformation change of domain III appears to move this
domain away from the top of domain II as suggested by our previous work showing that Arg602-Leu603 bond in the loop
between helices 6 and 7 becomes susceptible to trypsin attack (39).
This movement of domain III away from domain II could make the
environment of
Asp-213 more hydrophilic and lower its
pKa, resulting in proton release into the nearby
proton channel. Using the catalytically active cysteine-free mutant of
E. coli TH as the parent enzyme, Althage et al.
(42) have converted
Asp-213 and
Arg-265 separately and together
to Cys in this otherwise cysteine-free protein. They have shown that both
D213C and
R265C mutants react with a fluorescent maleimide and that the presence of NADP(H) considerably increases the
accessibility of the Cys residues to the maleimide derivative.
Arg-265 is located five residues beyond helix 14 at the junction
between domains II and III. When the fluorescent maleimide was added to
the double mutant
D213C/
R265C, it reacted poorly, suggesting to
the authors that the two Cys residues have formed a disulfide bond. The
authors infer from these data that in the native TH
Asp-213 and
Arg-265, which they consider is not an essential residue, form a
salt bridge. If so, this interaction would interfere with our proposed
role of
Asp-213 in proton conductance. However, Althage et
al. (42) state that their double mutant TH contained no bound
nucleotides and have shown as recounted above that the presence of
NADP(H) greatly increases the accessibility of
D213C and
R265C to
modification by the fluorescent maleimide. Therefore, it seems probable
that in the functioning enzyme substrate-promoted
conformation changes, which increase the solvent exposure of these
residues, would also prevent their coming together to form a salt
bridge and allow
Asp-213 to function in proton conductance.
Returning to the proposed mechanism, we would expect that in forward
transhydrogenation, incoming protons would follow the path described
above (i.e. through the hydrogen-bonded channel of domain II
to
Asp-213 and domain III), resulting in affinity increase for NADP,
which we have earlier shown (1, 4, 37, 38), and probably in affinity
decrease for NADPH as suggested by kinetic data.
|
| |
ACKNOWLEDGEMENTS |
|---|
We thank Maria Latev and Cristel Cortinas-Miller for expert technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported by the National Institutes of Health, United States Public Health Service Grants GM61545 and DK08126 (to Y. H.). Synthesis of nucleotides was supported in part by the Sam and Rose Stein Endowment Fund. This is publication number 14628-MEM from The Scripps Research Institute.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 858-784-8092; Fax: 858-784-2054; E-mail: hatefi@scripps.edu.
Published, JBC Papers in Press, June 26, 2002, DOI 10.1074/jbc.M204170200
2 G. S. Prasad, M. Wahlberg, V. Sridhar, Y. Sundaresan, M. Yamaguchi, Y. Hatefi, and C. D. Stout, submitted for publication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: TH, transhydrogenase; AcPyAD, 3-acetylpyridine adenine dinucleotide; AcPyADP, 3-acetypyridine adenine dinucleotide phosphate; ACMA, 9-amino-6-chloro-2-methoxyacridine; MES, 2-(N-morpholino)ethanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Hatefi, Y., and Yamaguchi, M. (1996) FASEB J. 10, 444-452[Abstract] |
| 2. | Jackson, J. B., Peake, S. J., and White, S. A. (1999) FEBS Lett. 464, 1-8[CrossRef] |
| 3. | Bizouarn, T., Fjellström, O., Meuller, J., Axelsson, M., Bergkvist, A., Johansson, C., Karlsson, B. G., and Rydström, J. (2000) Biochim. Biophys. Acta 1457, 211-228[Medline] [Order article via Infotrieve] |
| 4. | Hatefi, Y., and Yamaguchi, M. (1992) in Molecular Mechanisms in Bioenergetics (Ernster, L., ed) , pp. 265-281, Elsevier Science Publishers B.V., Amsterdam |
| 5. | Clarke, D. M., and Bragg, P. D. (1985) Eur. J. Biochem. 149, 517-523[Medline] [Order article via Infotrieve] |
| 6. | Lever, T. M., Palmer, T., Cunningham, I. J., Cotton, N. P. J., and Jackson, J. B. (1991) Eur. J. Biochem. 197, 247-255[Medline] [Order article via Infotrieve] |
| 7. |
Yamaguchi, M.,
and Hatefi, Y.
(1993)
J. Biol. Chem.
268,
17871-17877 |
| 8. |
Yamaguchi, M.,
and Hatefi, Y.
(1991)
J. Biol. Chem.
266,
5728-5735 |
| 9. |
Yamaguchi, M.,
and Hatefi, Y.
(1995)
J. Biol. Chem.
270,
28165-28168 |
| 10. | Yamaguchi, M., and Hatefi, Y. (1997) Biochim. Biophys. Acta 1318, 225-234[Medline] [Order article via Infotrieve] |
| 11. |
Venning, J. D.,
Grimley, R. L.,
Bizouarn, T.,
Cotton, N. P. J.,
and Jackson, J. B.
(1997)
J. Biol. Chem.
272,
27535-27538 |
| 12. | Venning, J. D., Bizouarn, T., Cotton, N. P. J., Quirk, P. G., and Jackson, J. B. (1998) Eur. J. Biochem. 257, 202-209[Medline] [Order article via Infotrieve] |
| 13. |
Pinheiro, T. J. T.,
Venning, J. D.,
and Jackson, J. B.
(2001)
J. Biol. Chem.
276,
44757-44761 |
| 14. | Prasad, G. S., Sridhar, V., Yamaguchi, M., Hatefi, Y., and Stout, C. D. (1999) Nat. Struct. Biol. 6, 1126-1131[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | White, S. A., Peake, S. J., McSweeney, S., Leonard, G., Cotton, N. P. J., and Jackson, J. B. (2000) Structure 8, 1-12[Medline] [Order article via Infotrieve] |
| 16. | Buckley, P. A., Jackson, J. B., Schneider, T., White, S. A., Rice, D. W., and Baker, P. J. (2000) Structure 8, 809-815[Medline] [Order article via Infotrieve] |
| 17. | Cotton, N. P. J., White, S. A., Peake, S. J., McSweeney, S., and Jackson, J. B. (2001) Structure 9, 165-176[Medline] [Order article via Infotrieve] |
| 18. |
Yamaguchi, M.,
and Hatefi, Y.
(1995)
J. Biol. Chem.
270,
16653-16659 |
| 19. | Kunkel, T. A., Roberts, J. D., and Zakour, R. A. (1987) Methods Enzymol. 154, 367-382[Medline] [Order article via Infotrieve] |
| 20. |
Meuller, J.,
and Rydström, J.
(1999)
J. Biol. Chem.
274,
19072-19080 |
| 21. | Fisher, R. R., and Earl, S. R. (1982) in The Pyridine Nucleotide Coenzymes (Everse, J. , Anderson, B. , and You, K.-S., eds) , pp. 279-324, Academic Press, Orlando, FL |
| 22. | Hutton, M., Day, J. M., Bizouarn, T., and Jackson, J. B. (1994) Eur. J. Biochem. 219, 1041-1051[Medline] [Order article via Infotrieve] |
| 23. | Olausson, T., Fjellström, O., Meuller, J., and Rydström, J. (1995) Biochim. Biophys. Acta 1231, 1-19[Medline] [Order article via Infotrieve] |
| 24. | Bragg, P. D., and Hou, C. (1999) Arch. Biochem. Biophys. 363, 182-190[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Glavas, N. A., Hou, C., and Bragg, P. D. (1995) Biochemistry 34, 7694-7702[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Bragg, P. D., and Hou, C. (1996) Eur. J. Biochem. 241, 611-618[Medline] [Order article via Infotrieve] |
| 27. | Bragg, P. D. (1998) Biochim. Biophys. Acta 1365, 98-104[Medline] [Order article via Infotrieve] |
| 28. | Bragg, P. D., and Hou, C. (2001) Arch. Biochem. Biophys. 388, 299-307[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Bizouarn, T., Meuller, J., Axelsson, M., and Rydström, J. (2000) Biochim. Biophys. Acta 1459, 284-290[Medline] [Order article via Infotrieve] |
| 30. | Lanyi, J. K. (1998) J. Struct. Biol. 124, 164-178[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Lanyi, J. K. (1999) Int. Rev. Cytol. 187, 161-202[Medline] [Order article via Infotrieve] |
| 32. | Maeda, A., Balashov, S. P., Luglenburg, J., Verhoeven, M. A., Herzfeld, J., Belenkg, M., Gennis, R. B., Tomson, F. L., and Ebrey, T. G. (2002) Biochemistry 41, 3803-3809[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Wikström, M., Morgan, J. E., and Verkhovsky, M. I. (1998) J. Bioenerg. Biomembr. 30, 139-145[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Zaslavsky, D., and Gennis, R. B. (2000) Biochim. Biophys. Acta 1458, 164-179[Medline] [Order article via Infotrieve] |
| 35. | Wikström, M. (2000) Biochim. Biophys. Acta 1458, 188-198[Medline] [Order article via Infotrieve] |
| 36. |
Hatefi, Y.,
Phelps, D. C.,
and Galante, Y. M.
(1980)
J. Biol. Chem.
255,
9526-9529 |
| 37. |
Galante, Y. M.,
Lee, Y.,
and Hatefi, Y.
(1980)
J. Biol. Chem.
255,
9641-9646 |
| 38. |
Hatefi, Y.,
Yagi, T.,
Phelps, D. C.,
Wong, S.-Y.,
Vik, S. B.,
and Galante, Y. M.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
1756-1760 |
| 39. | Yamaguchi, M., Wakabayashi, S., and Hatefi, Y. (1990) Biochemistry 29, 4136-4143[CrossRef][Medline] [Order article via Infotrieve] |
| 40. | Tong, R. C. W., Glavas, N. A., and Bragg, P. D. (1991) Biochim. Biophys. Acta 1080, 19-28[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Hu, X., Zhang, J., Fjellström, O., Bizouarn, T., and Rydström, J. (1999) Biochemistry 38, 1652-1658[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Althage, M., Bizouarn, T., and Rydström, J. (2001) Biochemistry 40, 9968-9976[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
M. Yamaguchi and C. D. Stout Essential Glycine in the Proton Channel of Escherichia coli Transhydrogenase J. Biol. Chem., November 14, 2003; 278(46): 45333 - 45339. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals |